Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$84.3 - $94.31 $3,372 - $3,772
40 Added 1.66%
2,448 $226 Million
Q1 2024

Apr 19, 2024

SELL
$72.54 - $95.56 $54,985 - $72,434
-758 Reduced 23.94%
2,408 $230 Million
Q4 2023

Apr 19, 2024

SELL
$61.71 - $77.76 $126,875 - $159,874
-2,056 Reduced 39.37%
3,166 $241 Million
Q3 2023

Apr 19, 2024

BUY
$69.28 - $93.38 $175,694 - $236,811
2,536 Added 94.42%
5,222 $362 Million
Q2 2023

Apr 22, 2024

SELL
$81.41 - $94.33 $7,896 - $9,150
-97 Reduced 3.4%
2,752 $260 Million
Q1 2023

Apr 22, 2024

BUY
$74.26 - $84.51 $32,748 - $37,268
441 Added 18.31%
2,849 $236 Million
Q4 2022

Apr 19, 2024

SELL
$68.3 - $87.44 $21,104 - $27,018
-309 Reduced 10.32%
2,686 $200 Million
Q3 2022

Apr 19, 2024

BUY
$82.37 - $107.29 $494 - $643
6 Added 0.2%
2,995 $247 Million
Q2 2022

Apr 19, 2024

SELL
$86.5 - $128.27 $402,484 - $596,840
-4,653 Reduced 60.89%
2,989 $284 Million
Q1 2022

Apr 19, 2024

SELL
$101.96 - $128.34 $22,329 - $28,106
-219 Reduced 2.79%
7,642 $900 Million
Q4 2021

Apr 19, 2024

BUY
$106.37 - $130.68 $62,864 - $77,231
591 Added 8.13%
7,861 $1.02 Billion
Q3 2021

Apr 19, 2024

BUY
$102.91 - $122.75 $69,258 - $82,610
673 Added 10.2%
7,270 $823 Million
Q2 2021

Apr 19, 2024

SELL
$83.84 - $104.76 $240,285 - $300,242
-2,866 Reduced 30.29%
6,597 $683 Million
Q1 2021

Apr 19, 2024

SELL
$78.68 - $90.67 $73,644 - $84,867
-936 Reduced 9.0%
9,463 $791 Million
Q4 2020

Apr 19, 2024

BUY
$71.69 - $91.23 $160,585 - $204,355
2,240 Added 27.45%
10,399 $949 Million
Q3 2020

Apr 19, 2024

BUY
$67.19 - $87.44 $288,715 - $375,729
4,297 Added 111.26%
8,159 $651 Million
Q2 2020

Apr 19, 2024

BUY
$57.54 - $76.95 $222,219 - $297,180
3,862 New
3,862 $267 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $44B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Ashton Thomas Private Wealth, LLC Portfolio

Follow Ashton Thomas Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashton Thomas Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ashton Thomas Private Wealth, LLC with notifications on news.